Follow Us
Mental HealthNews

FDA May Soon Approve Version of 'Special K' for Severe Depression

Larry Bryant Jr.
Larry Bryant Jr. has been managing depression for much of his life, but prefers not to take antidepressants due to side effect concerns. He's encouraged by the potential future approval of an FDA-approved variant of ketamine. (PhotoLarry Bryant Jr.
    Tim Murphy

    Tim Murphy


    Tim Murphy, based in Brooklyn, has been writing about HIV/AIDS for 25 years, for publications and organizations including TheBody, TheBodyPro, POZ, New York Magazine, The Nation, Housing Works, and Lambda Legal.